NCT02794376

Brief Summary

This study investigates the effectiveness of a 6 week mindfulness intervention in reducing symptoms of Irritable Bowel Syndrome (IBS). All Participants will receive treatment. Participants will be randomly allocated to an immediate treatment group and a waiting list control group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 19, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 9, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2017

Completed
Last Updated

October 27, 2017

Status Verified

October 1, 2017

Enrollment Period

1.2 years

First QC Date

May 19, 2016

Last Update Submit

October 25, 2017

Conditions

Keywords

IBS

Outcome Measures

Primary Outcomes (1)

  • Change in IBS symptom Severity (GSRS - IBS)

    Self-Report Questionnaire

    Baseline and Post Intervention (within the first three weeks of completion or the intervention)

Secondary Outcomes (18)

  • Changes in IBS quality of Life (IBS-QOL)

    Baseline and Post Intervention Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)

  • Changes in Psychological Distress (DASS)

    Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)

  • Changes in Positive and Negative Emotions (PANAS)

    Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)

  • Changes in IBS catastrophizing (GI-Cognitions Questionniare)

    Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)

  • Changes in Visceral Anxiety Sensitivity (VSI)

    Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)

  • +13 more secondary outcomes

Study Arms (2)

Immediate Treatment Group

EXPERIMENTAL

Mindfulness course consisting of six weekly two hour mindfulness sessions plus meditation homework assignments.

Behavioral: Mindfulness Based Cognitive Therapy (MBCT)

Delayed Treatment Group

OTHER

Waiting period plus Mindfulness course consisting of six weekly two hour mindfulness sessions plus meditation homework assignments after the waiting period has finished.

Behavioral: Mindfulness Based Cognitive Therapy (MBCT)Behavioral: Waiting Period

Interventions

Delayed Treatment GroupImmediate Treatment Group
Waiting PeriodBEHAVIORAL
Delayed Treatment Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Participants speaks English fluently or at a native level
  • Participant has normal or corrected to normal vision

You may not qualify if:

  • Participant has insufficient manual dexterity for the computerized tasks
  • Severe Diagnostic and Statistical Manual (DSM) Axis I or II psychiatric disorder (diagnosis of dementia, amnesia, delirium, a dissociative disorder, a personality disorder, schizophrenia or any other psychotic disorder, a substance-related or induced disorder (such as alcoholism), attention deficit hyperactivity disorder (ADHD), attention deficit disorder (ADD), primary diagnosis of obsessive compulsive disorder (OCD), current suicidality, regular non-suicidal self-injury.
  • Recent bereavement (within one year)
  • GI diagnosis other than IBS (IBD, coeliac disease, another FGID)
  • Pregnancy
  • No access to the internet
  • Prior participation in an 8-week mindfulness course (MBSR, MBCT) or any other structured mindfulness training. Prior participation in Vipassana meditation courses. Regular meditation practice (meditating more than once per month).
  • Not able or unwilling to commit to amount of practice (sessions and home practice).
  • Participant is currently enrolled in another IBS treatment study (psychological or pharmacological).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Henrich JF, Gjelsvik B, Surawy C, Evans E, Martin M. A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome-Effects and mechanisms. J Consult Clin Psychol. 2020 Apr;88(4):295-310. doi: 10.1037/ccp0000483.

MeSH Terms

Conditions

Irritable Bowel Syndrome

Interventions

Mindfulness-Based Cognitive Therapy

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2016

First Posted

June 9, 2016

Study Start

April 14, 2016

Primary Completion

July 10, 2017

Study Completion

July 10, 2017

Last Updated

October 27, 2017

Record last verified: 2017-10